Zucovog 0.2mg Tablet DT
Marketer
Zuciya Lifesciences
Salt Composition
Voglibose (0.2mg)
Overview Zucovog 0.2mg Tablet DT
Diabeva 0.2mg tablets are indicated for managing type 2 diabetes. This medication aids in postprandial blood glucose regulation, employed when dietary modifications and other comparable therapies prove insufficient to maintain glycemic control. Diabeva 0.2mg tablets should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar management. Discontinuing this medication abruptly is contraindicated; doing so may elevate blood glucose, risking severe complications such as renal impairment and vision loss. This medication forms one component of a comprehensive treatment strategy encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include abdominal discomfort, flatulence, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabeva 0.2mg tablets alone do not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose should be used to treat hypoglycemic episodes; sucrose is ineffective in this context. Prior to initiating treatment, disclose any hepatic or renal dysfunction to your doctor. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. Comprehensive disclosure of all concurrent medications is crucial for patient safety. Excessive alcohol consumption should be avoided due to a heightened hypoglycemia risk.
Primary Ingredients of Zucovog 0.2mg Tablet DT
No text provided. Please provide the text you wish me to rephrase.
Uses of Zucovog 0.2mg Tablet DT
Managing type 2 diabetes
Major Benefits of Zucovog 0.2mg Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Zucovog 0.2mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Zucovog 0.2mg Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Zucovog 0.2mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Zucovog 0.2mg Tablet DT in water before consumption. Administer on an empty stomach.
How Zucovog 0.2mg Tablet DT works:
Zucovog 0.2mg delayed-release tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates, thus preventing postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zucovog 0.2mg Tablet DT and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Zucovog 0.2mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Zucovog 0.2mg Tablet DT appear compatible. Preliminary evidence from human studies indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Zucovog 0.2mg Tablet DT.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Zucovog 0.2mg Tablet DT. Dosage modification of Zucovog 0.2mg Tablet DT might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Zucovog 0.2mg Tablet DT cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Zucovog 0.2mg Tablet DT :
Should you forget a Zucovog 0.2mg Tablet DT dose, omit it and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Zucovog 0.2mg Tablet DT
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently